3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
CNS
1
Conditions
Spinal Cord Neoplasms
1
Neurofibrosarcoma
1
Neurofibroma
1
Nerve Sheath Neoplasms
1
Interventions
Magnetic Resonance Spectroscopy
3
AZD 6244
3
fludarabine phosphate
2
Specimen Handling
2
Nivolumab
2
Etoposide
2
thymoglobulin
1
pembrolizumab
1
lorvotuzumab mertansine
1
fludarabine
1
X-Rays
1
Trabectedin
1
Thiotepa
1
Tacrolimus
1
Surgical Procedures, Operative
1
Stem Cell Transplantation
1
Sirolimus
1
Radiotherapy
1
Photons
1
Neurofibromin 1
1
Mycophenolic Acid
1
Mesna
1
Melphalan
1
Liquid Biopsy
1
Ipilimumab
1
Imatinib Mesylate
1
Ifosfamide
1
High-Energy Shock Waves
1
Filgrastim
1
Doxorubicin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neurofibrosarcoma
×
Neurofibromin 1
×
CNS
×
Clear all
NCT01567787
2017-02-10
NF01
University of Florida
Phase NA
Withdrawn